West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

West Pharmaceutical Services (WST) stock was upgraded to Buy at Deutsche Bank due to an attractive entry point post-selloff. Read more here.

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

West Pharmaceutical expects full-year earnings in the range of $6 to $6.20 per share, with revenue in the range of $2.88 billion to $2.91 billion. This story was generated by Automated Insights ( http ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...